Loading...
StocksRunner logo
 
 
Baxter International
42.13
+2.87%
 
BAX Baxter International
Last Price
Change
42.13
 
+2.87%
 
 
 

 
Sentiment
 
  Login to display
 
 

46.8

38.14

45.69

66.78

 
 
1m
3m
6m
1y
 

Summary

  Login to display Baxter International (BAX) recommendation from the last 90 days from financial news and social media.
 

Strengths

Rewards

 Earnings are forecast to grow

Rewards

 Upgraded on attractively valued

 
 

Risk Level

 
StocksRunner
 

Baxter International (BAX) has Low Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 

Earnings

×
 

Earnings

4.00
 

StocksRunner

 Above analyst estimates

 
 

Rating

×
 

Rating

5.00
 

StocksRunner

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

2.50
 
 

Activity

×
 

Activity

3.42
 
 

Future

×
 

Future

3.67
 

StocksRunner

 Earnings are forecast to grow

 
 

Analysts Opinion

Analysts opinion is positive and also has improved from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
60%
100%
0%
67%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is bullish and have positive views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
60%
5%
Positive
Negative
12 out of 20
events present
1 out of 20
events present
 

 
Events Calendar
Click for more information
 
May
S
M
T
W
T
F
S
June
S
M
T
W
T
F
S
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Dividend Declares
1 Week Ago
40.31
-2.37%
 
Dividend Declares
2 Month Ago
46.57
-0.94%
 
Buy Rating
2 Month Ago
47.75
+1.99%
 
Strong Earnings
2 Month Ago
46.80
+1.56%
 
Top Headlines

ex-dividend reminder: baxter international mckesson and universal health services. looking at the universe of stocks we cover at dividend channel on 6/1/23 baxter international inc (symbol: bax) mckesson corp (symbol: mck) and universal heal

Tue May 30, 2023

Activity

artivion wins fda nod for baxter-partnered clotting product.

Tue May 23, 2023

Activity

baxter international cfo jay saccaro quits brian stevens named acting finance chief. (rttnews) - baxter international inc. (bax) a healthcare product developer announced on tuesday that its chief financial officer jay saccaro will step down at t

Tue May 9, 2023

Activity
Potential

warburg advent to buy baxters biopharma business for $4.25 billion. baxter international inc said on monday a private-equity group which includes warburg pincus and advent international has agreed to buy its biopharma solutions unit for $4.25 bi

Mon May 8, 2023

Activity

advent warburg pincus lead multi-billion buyout bid for baxters biopharma solutions. a buyout consortium comprising warburg pincus and advent international is in advanced talks to acquire)

Mon May 8, 2023

Activity

baxter appoints chris toth head of kidney care spinoff.

Fri May 5, 2023

Activity

baxter international (bax) declares $0.29 dividend. baxter international said on may 1 2023 that its board of directors declared a regular quarterly dividend of $0.29 per share ($1.16 annualized). previously the company paid

Wed May 3, 2023

Activity

baxter declares $0.29 dividend.

Mon May 1, 2023

Activity

barclays maintains baxter international (bax) overweight recommendation. fintel reports that on may 1 2023 barclays maintained coverage of baxter international (nyse:bax) with a overweight recommendation.

Mon May 1, 2023

Rating

stifel maintains baxter international (bax) buy recommendation. fintel reports that on april 28 2023 stifel maintained coverage of baxter international (nyse:bax) with a buy recommendation.

Fri Apr 28, 2023

Rating

baxter (bax) beats on q1 earnings ups 23 eps view. baxter international inc. bax reported first-quarter 2023 adjusted earnings per share (eps) of 59 cents which beat the zacks consensus estimate of 48 cents. however the bottom line dec

Thu Apr 27, 2023

Earnings
Potential

baxter international (bax) q1 earnings and revenues top estimates. baxter international (bax) came out with quarterly earnings of $0.59 per share beating the zacks consensus estimate of $0.48 per share. this compares to earnings of $0.

Thu Apr 27, 2023

Earnings

baxter international q1 results top estimates. boosts fy23 adj. eps outlook. (rttnews) - health care company baxter international inc. (bax) reported thursday that net income attributable to baxter for the first quarter declined to $44 million o

Thu Apr 27, 2023

Earnings

scottsmiracle-gro provides update on fiscal q2 2023 announces nate baxter joining executive team. ) announced that it the company expects final q2 net leverage in the range of 6.0 reflecting the disciplined approach to cost control focus on improved eff

Mon Apr 10, 2023

Potential

baxters (bax) new premix drug now available in the United States. baxter international inc. bax recently announced the United States launch of zosyn (piperacillin and tazobactam) injection. zosyn premix indicated for treating multiple

Mon Apr 10, 2023

Activity

scottsmiracle-gro appoints nate baxter as executive vice president. (rttnews) - the scotts miracle-gro company (smg) a provider of gardening resources announced on monday that it has appointed nate baxter as executive vice president technology a

Mon Apr 10, 2023

Activity

 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our daily BAX alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
StocksRunner

StocksRunner

Get the pulse of the market

 
StocksRunner

BAX Baxter International

Last Price
42.13
Change
+2.87%
 

Summary

  Login to display Baxter International (BAX) recommendation from the last 90 days from financial news and social media.

 
 
46.8
38.14
45.69
66.78
 
 
1m
3m
6m
1y
 
Sentiment
 

  Login to display

Strengths

Rewards

 Earnings are forecast to grow

Rewards

 Upgraded on attractively valued

 
 
 
 
Street Consensus
 
Buy
Opinion
Trend
Score
Potential
Score
 
100%
0%
67%
On Track
On Track
On Track
 
60%
5%
Positive
Negative
12 out of 20
events present
1 out of 20
events present
 

Street Opinion

Street view is bullish and have positive views on the near-term outlook

 
 
Analysts Opinion
Hover the category for more information
 
 

Earnings

×
 

Earnings

4.00
 

StocksRunner

 Above analyst estimates

 
 

Rating

×
 

Rating

5.00
 

StocksRunner

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

2.50
 
 

Activity

×
 

Activity

3.42
 
 

Future

×
 

Future

3.67
 

StocksRunner

 Earnings are forecast to grow

 
 

Analysts Opinion

Analysts opinion is positive and also has improved from the past 3 months

 
 
 
 
 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Risk Level
 
StocksRunner
 

Baxter International (BAX) has Low Risk Level.  Click here to check what is your level of risk

 
 
 

Events Calendar

Hover for information

 
May
 
S
M
T
W
T
F
S
 
June
 
S
M
T
W
T
F
S
 
 
 
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Dividend Declares
1 Week Ago
40.31
-2.37%
 
Dividend Declares
2 Month Ago
46.57
-0.94%
 
Buy Rating
2 Month Ago
47.75
+1.99%
 
Strong Earnings
2 Month Ago
46.80
+1.56%
 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our daily BAX Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
 
 

Top Headlines